LINDA MOSBY: Open Payments
NPI 1578559605 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 35 payments from 11 companies in 2025. Trend: 2023 $985 · 2024 $703 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $203 |
| C2N Diagnostics, LLC | 3 | $170 |
| Kowa Pharmaceuticals America, Inc. | 4 | $152 |
| GlaxoSmithKline, LLC. | 4 | $105 |
| Dexcom, Inc. | 1 | $83 |
| Abbott Laboratories | 3 | $67 |
| Lilly USA, LLC | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Dynavax Technologies Corporation | 2 | $37 |
| PFIZER INC. | 1 | $18 |
Products named: Ozempic, PRECIVITYAD2, ZORYVE, TRELEGY ELLIPTA, DEXCOM G7 GSS (161), FREESTYLE LIBRE 3, Kerendia, JARDIANCE.
Industry payments across TN — which companies pay providers there.
